ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $709 | -16.9% | 17,526 | -4.4% | 0.01% | -16.7% |
| Q4 2022 | $853 | -99.9% | 18,338 | -5.5% | 0.01% | -25.0% |
| Q3 2022 | $1,006,000 | +9.7% | 19,400 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $917,000 | -33.6% | 19,400 | 0.0% | 0.01% | -12.5% |
| Q1 2022 | $1,381,000 | +31.0% | 19,400 | +37.2% | 0.01% | +60.0% |
| Q4 2021 | $1,054,000 | +123.3% | 14,141 | +50.4% | 0.01% | +25.0% |
| Q2 2020 | $472,000 | -85.3% | 9,400 | -85.0% | 0.00% | -76.5% |
| Q1 2020 | $3,220,000 | +57.0% | 62,600 | +88.6% | 0.02% | +6.2% |
| Q4 2019 | $2,051,000 | +18.1% | 33,200 | +14.9% | 0.02% | +6.7% |
| Q3 2019 | $1,736,000 | -14.3% | 28,900 | +20.4% | 0.02% | -11.8% |
| Q2 2019 | $2,025,000 | -29.1% | 24,000 | -19.7% | 0.02% | -34.6% |
| Q1 2019 | $2,856,000 | +16.9% | 29,900 | -13.3% | 0.03% | +18.2% |
| Q4 2018 | $2,444,000 | +63.3% | 34,500 | -49.2% | 0.02% | +29.4% |
| Q2 2016 | $1,497,000 | -67.4% | 67,900 | -56.6% | 0.02% | -67.3% |
| Q1 2016 | $4,593,000 | -28.6% | 156,400 | -18.8% | 0.05% | -37.3% |
| Q4 2015 | $6,437,000 | – | 192,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |